Moreover, also in line with our findings, the alarmin IL‐33 and ST2 pathway that has been connected to a pro‐tumourigenic role in tumour‐infiltrating immune cells31, 32 and may be a further strategy to overcome the limited lymphocyte function within the TME. This evidence concerns the gene IL33 and neoplasm.